AVI BioPharma Names Waggener Edstrom Its PR Agency of Record.Business Editors, Health/Medical Writers PORTLAND, Ore.--(BW HealthWire)--Jan. 31, 2002 AVI BioPharma Inc. (Nasdaq:AVII)(Nasdaq:AVIIW)(Nasdaq:AVIIZ) has selected Waggener Edstrom Strategic Communications to create and implement a national public relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most campaign as the company's agency of record. AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using two technology platforms: cancer immunotherapy and gene-targeted drugs. AVI (Audio Video Interleaved) A Windows multimedia video format from Microsoft. It interleaves standard waveform audio and digital video frames (bitmaps) to provide reduced animation at 15 fps at 160x120x8 resolution. Audio is 11,025Hz, 8-bit samples. did not issue a formal request for proposal for the public relations business, but spoke individually to a few select firms. "Waggener Edstrom's record of building awareness for companies at all stages of business development, combined with an obvious passion to succeed in the bioscience area, won the account," said Alan P. Timmins, president and chief operating officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of AVI BioPharma. "The Waggener Edstrom team also demonstrated a strong understanding of our business and market realities -- something that's critical for our joint success." "AVI BioPharma has the late-stage clinical research, innovative technologies and strong management that will serve it well in the long term," said Melissa Waggener, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Waggener Edstrom. "We also find the company's openness and positive outlook incredibly refreshing. We can't wait to get started and look forward to delivering great results." Jenny Moede, vice president, and Colleen Beauregard, account manager, will be responsible for strategic direction and day-to-day management of the account. About Waggener Edstrom Strategic Communications Waggener Edstrom is a strategic public relations Strategic Public Relations (PR) involves creative planning, media research and strategic approach in designing a PR campaign. Unlike the present, PR programs used to be very media relations-centric and based on personal relationships with journalists and columnists. agency with a focus on clients that use science and technology to transform the way people work and live. Waggener Edstrom Bioscience, a division of the company, is focused on building established science companies into global brands as well as extending brand awareness for start-up companies with high-potential research platforms. In addition to AVI BioPharma, current agency clients include Microsoft Corp., MasterCard International and Cortex Pharmaceuticals Inc. About AVI BioPharma AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using two technology platforms: cancer immunotherapy and gene-targeted drugs. Its lead clinical agent, AVICINE(TM), a therapeutic cancer vaccine, has completed two Phase II trials in pancreatic cancer pancreatic cancer Malignant tumour of the pancreas. Risk factors include smoking, a diet high in fat, exposure to certain industrial products, and diseases such as diabetes and chronic pancreatitis. Pancreatic cancer is more common in men. and is in a Phase III pivotal trial in colorectal cancer. The first application of its NEUGENE compounds, Resten-NG, is designed to treat cancer, cardiovascular restenosis and other cell proliferation disorders by inhibiting the production of a cellular transcription factor, the oncogene oncogene Gene that can cause cancer. It is a sequence of DNA that has been altered or mutated from its original form, the proto-oncogene (see mutation). Proto-oncogenes promote the specialization and division of normal cells. c-myc. It is currently in Phase II trials for restenosis, Phase I/II trials for cancer and Phase I trial for polycystic kidney disease Polycystic Kidney Disease Definition Polycystic kidney disease (PKD) is one of the most common of all life-threatening human genetic disorders. . More information about AVI is available on the Company's Web site at http://www.avibio.com/. "Safe Harbor" Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the Company's Securities and Exchange Commission filings. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion